Accumulated clinical data support that the core cerebrospinal fluid (CSF) biomarkers, amyloid β (Aβ42), total Tau (T-Tau) and phosphorylated Tau (P-Tau), reflect key pathophysiological factors in AD (Blennow and Zetterberg, 2018). This evidence concerns the gene MAPT and Alzheimer disease.